Tamara Kögl
Hat mitgewirkt an:
-
Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice
-
Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH)
-
Eomes cannot replace its paralog T-bet during expansion and differentiation of CD8 effector T cells
-
Trigger‐dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis